Pediatric Nephrology, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas.
Pediatric Rheumatology, Perelman School of Medicine at the University of Pennsylvania, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Clin J Am Soc Nephrol. 2022 Jan;17(1):65-74. doi: 10.2215/CJN.07810621. Epub 2021 Nov 3.
Performing adequately powered clinical trials in pediatric diseases, such as SLE, is challenging. Improved recruitment strategies are needed for identifying patients.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Electronic health record algorithms were developed and tested to identify children with SLE both with and without lupus nephritis. We used single-center electronic health record data to develop computable phenotypes composed of diagnosis, medication, procedure, and utilization codes. These were evaluated iteratively against a manually assembled database of patients with SLE. The highest-performing phenotypes were then evaluated across institutions in PEDSnet, a national health care systems network of >6.7 million children. Reviewers blinded to case status used standardized forms to review random samples of cases (=350) and noncases (=350).
Final algorithms consisted of both utilization and diagnostic criteria. For both, utilization criteria included two or more in-person visits with nephrology or rheumatology and ≥60 days follow-up. SLE diagnostic criteria included absence of neonatal lupus, one or more hydroxychloroquine exposures, and either three or more qualifying diagnosis codes separated by ≥30 days or one or more diagnosis codes and one or more kidney biopsy procedure codes. Sensitivity was 100% (95% confidence interval [95% CI], 99 to 100), specificity was 92% (95% CI, 88 to 94), positive predictive value was 91% (95% CI, 87 to 94), and negative predictive value was 100% (95% CI, 99 to 100). Lupus nephritis diagnostic criteria included either three or more qualifying lupus nephritis diagnosis codes (or SLE codes on the same day as glomerular/kidney codes) separated by ≥30 days or one or more SLE diagnosis codes and one or more kidney biopsy procedure codes. Sensitivity was 90% (95% CI, 85 to 94), specificity was 93% (95% CI, 89 to 97), positive predictive value was 94% (95% CI, 89 to 97), and negative predictive value was 90% (95% CI, 84 to 94). Algorithms identified 1508 children with SLE at PEDSnet institutions (537 with lupus nephritis), 809 of whom were seen in the past 12 months.
Electronic health record-based algorithms for SLE and lupus nephritis demonstrated excellent classification accuracy across PEDSnet institutions.
在儿科疾病(如系统性红斑狼疮)中开展充分效能的临床试验颇具挑战。需要改进招募策略以识别患者。
设计、地点、参与者和测量方法:开发并测试了电子病历算法,以识别有或无狼疮肾炎的系统性红斑狼疮患儿。我们使用单中心电子病历数据,构建由诊断、用药、操作和利用代码组成的可计算表型。这些表型经过反复迭代,与手动组装的系统性红斑狼疮患者数据库进行了比较。然后,在全国儿童健康照护系统网络(PEDSnet)中的多个机构中评估表现最佳的表型,该网络包含超过 670 万儿童。对病例状态不知情的审核员使用标准化表格审核了病例(=350 例)和非病例(=350 例)的随机样本。
最终的算法包含利用和诊断标准。对于两者而言,利用标准包括与肾病或风湿病学专家进行两次或更多次当面就诊,以及≥60 天的随访。系统性红斑狼疮的诊断标准包括无新生儿狼疮、羟氯喹的单次或多次暴露,以及≥30 天间隔的三个或更多个合格诊断代码,或一个或多个诊断代码和一个或多个肾脏活检操作代码。敏感性为 100%(95%置信区间[95%CI],99 至 100),特异性为 92%(95%CI,88 至 94),阳性预测值为 91%(95%CI,87 至 94),阴性预测值为 100%(95%CI,99 至 100)。狼疮肾炎的诊断标准包括≥30 天间隔的三个或更多个合格狼疮肾炎诊断代码(或肾小球/肾脏代码与狼疮代码同一天),或一个或多个狼疮诊断代码和一个或多个肾脏活检操作代码。敏感性为 90%(95%CI,85 至 94),特异性为 93%(95%CI,89 至 97),阳性预测值为 94%(95%CI,89 至 97),阴性预测值为 90%(95%CI,84 至 94)。基于电子病历的算法在 PEDSnet 机构中识别出了 1508 名系统性红斑狼疮患儿(537 名伴有狼疮肾炎),其中 809 名患儿在过去 12 个月内就诊过。
基于电子病历的系统性红斑狼疮和狼疮肾炎算法在 PEDSnet 机构中表现出了优异的分类准确性。